BioNTech navigates colorectal trial halt, potential factory sales, and CEO transition while lung cancer data looms in Seoul.

SpaceX juggles Crew-13 leak delay, record launch pace, and AI unit leadership reshuffle as a Sept. 30 GPU deadline nears.

Hensoldt shares fall 1.7% despite India order; sector-wide sell-off and insider selling weigh, while order backlog tops €10B.

Despite record-breaking GTA VI trailer and pre-launch buzz, Take-Two shares drop 15% YTD amid leak probe and NBA 2K27 ...

Redwood AI spends C$960K on visibility deals as shares slide 8% post-QUANTUM.IQ acquisition, with volatility at 153%.

Vanguard's FTSE Global All-Cap UCITS ETF surpassed $1B in assets two weeks after launch, while the flagship All-World fund ...

Vonovia shares near 52-week low as analysts diverge on German real estate outlook, despite solid rental growth and easing ...

There is a peculiar moment unfolding in the AI trade right now, and Broadcom's latest earnings report captures it in sharp ...

Allianz posts record Q2 operating profit of €4.9B and H1 profit up 8.6%, yet Barclays keeps Underweight with €353 target, ...

Micron's Q4 report on Sept 30 tests a 247% rally amid a management transition and Taiwan strike threat, with 2027 guidance in focus.

Almonty shares surge 320% in a year, but Sangdong mine's production ramp will test whether the bullish Jefferies target holds.

Bayer's $7.25B Roundup settlement faces pivotal September 14 hearing after court clears path; UBS sees 27% upside with EUR 62 ...